Understanding the links between cardiovascular disease and Parkinson's disease

被引:97
作者
Potashkin, Judy [1 ]
Huang, Xuemei [2 ,3 ]
Becker, Claudia [4 ]
Chen, Honglei [5 ]
Foltynie, Thomas [6 ]
Marras, Connie [7 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL USA
[2] Penn State Coll Med, Translat Brain Res Ctr, Hershey, PA USA
[3] Penn State Coll Med, Dept Neurol, Hershey, PA USA
[4] Univ Basel, Basel Pharmacoepidemiol Unit, Div Clin Pharm & Epidemiol, Dept Pharmaceut Sci, Basel, Switzerland
[5] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA
[6] UCL, Inst Neurol, Dept Clin & Movement Neurosci, Queen Sq, London, England
[7] Univ Toronto, Toronto Western Hosp, Edmond J Safra Program Parkinsons Res, Toronto, ON, Canada
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
cardiovascular; Parkinson's disease; pathogenesis; risk factors; C-REACTIVE PROTEIN; RECREATIONAL PHYSICAL-ACTIVITY; VASCULAR RISK-FACTORS; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; BRAIN CHOLESTEROL; PLASMA CERAMIDES; LDL-CHOLESTEROL;
D O I
10.1002/mds.27836
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Studies investigating the associations between genetic or environmental factors and Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular disease, either as risk factors or manifestations of cardiovascular disease itself. Older age, male sex, and possibly type 2 diabetes are examples. On the other hand, coffee consumption and physical activity are each associated with a lower risk of both PD and cardiovascular disease. This observation raises questions about the underlying pathophysiological links between cardiovascular disease and PD. There is evidence for common mechanisms in the areas of glucose metabolism, cellular stress, lipid metabolism, and inflammation. On the other hand, smoking and total/low-density lipoprotein cholesterol appear to have opposite associations with cardiovascular disease and PD. Thus, it is uncertain whether the treatment of cardiovascular risk factors will impact on the onset or progression of PD. The available data suggest that a nuanced approach is necessary to manage risk factors such as cholesterol levels once the associations are better understood. Ultimately, the choice of therapy may be tailored to a patient's comorbidity profile. This review presents the epidemiological evidence for both concordant and discordant associations between cardiovascular disease and PD, discusses the cellular and metabolic processes that may underlie these links, and explores the implications this has for patient care and future research. (c) 2019 International Parkinson and Movement Disorder Society
引用
收藏
页码:55 / 74
页数:20
相关论文
共 164 条
[1]   Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease [J].
Abbott, Sarah K. ;
Li, Hongyun ;
Munoz, Sonia Sanz ;
Knoch, Bianca ;
Batterham, Marijka ;
Murphy, Karen E. ;
Halliday, Glenda M. ;
Garner, Brett .
MOVEMENT DISORDERS, 2014, 29 (04) :518-526
[2]   SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease [J].
Alcalay, Roy N. ;
Mallett, Victoria ;
Vanderperre, Benot ;
Tavassoly, Omid ;
Dauvillier, Yves ;
Wu, Richard Y. J. ;
Ruskey, Jennifer A. ;
Leblond, Claire S. ;
Ambalavanan, Amirthagowri ;
Laurent, Sandra B. ;
Spiegelman, Dan ;
Dionne-Laporte, Alexandre ;
Liong, Christopher ;
Levy, Oren A. ;
Fahn, Stanley ;
Waters, Cheryl ;
Kuo, Sheng-Han ;
Chung, Wendy K. ;
Ford, Blair ;
Marder, Karen S. ;
Kang, Un Jung ;
Hassin-Baer, Sharon ;
Greenbaum, Lior ;
Trempe, Jean-Francois ;
Wolf, Pavlina ;
Oliva, Petra ;
Zhang, Xiaokui Kate ;
Clark, Lorraine N. ;
Langlois, Melanie ;
Dion, Patrick A. ;
Fon, Edward A. ;
Dupre, Nicolas ;
Rouleau, Guy A. ;
Gan-Or, Ziv .
MOVEMENT DISORDERS, 2019, 34 (04) :526-535
[3]   The association between Mediterranean diet adherence and Parkinson's disease [J].
Alcalay, Roy N. ;
Gu, Yian ;
Mejia-Santana, Helen ;
Cote, Lucien ;
Marder, Karen S. ;
Scarmeas, Nikolaos .
MOVEMENT DISORDERS, 2012, 27 (06) :771-774
[4]   Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation [J].
Anchah, Lawrence ;
Hassali, Mohamed Azmi ;
Lim, Melissa Siaw Han ;
Ibrahim, Mohamed Izham Mohamed ;
Sim, Kui Hian ;
Ong, Tiong Kiam .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
[5]   Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease [J].
Andican, Gulnur ;
Konukoglu, Dildar ;
Bozluolcay, Melda ;
Bayulkem, Kemal ;
Firtiina, Sinem ;
Burcak, Gulden .
ACTA NEUROLOGICA BELGICA, 2012, 112 (02) :155-159
[6]   Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations [J].
Arkadir, David ;
Dinur, Tama ;
Mullin, Stephen ;
Mehta, Atul ;
Baris, Hagit N. ;
Alcalay, Roy N. ;
Zimran, Ari .
BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 :115-116
[7]   Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].
Ascherio, A ;
Zhang, SMM ;
Hernán, MA ;
Kawachi, I ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63
[8]   Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease A Secondary Analysis of the Exenatide-PD Trial [J].
Athauda, Dilan ;
Gulyani, Seema ;
Karnati, Hanuma Kumar ;
Li, Yazhou ;
Tweedie, David ;
Mustapic, Maja ;
Chawla, Sahil ;
Chowdhury, Kashfia ;
Skene, Simon S. ;
Greig, Nigel H. ;
Kapogiannis, Dimitrios ;
Foltynie, Thomas .
JAMA NEUROLOGY, 2019, 76 (04) :420-429
[9]   Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial [J].
Athauda, Dilan ;
Maclagan, Kate ;
Skene, Simon S. ;
Bajwa-Joseph, Martha ;
Letchford, Dawn ;
Chowdhury, Kashfia ;
Hibbert, Steve ;
Budnik, Natalia ;
Zampedri, Luca ;
Dickson, John ;
Li, Yazhou ;
Aviles-Olmos, Iciar ;
Warner, Thomas T. ;
Limousin, Patricia ;
Lees, Andrew J. ;
Greig, Nigel H. ;
Tebbs, Susan ;
Foltynie, Thomas .
LANCET, 2017, 390 (10103) :1664-1675
[10]   Soy protein intake, carchorenal indices, and C-reactive protein in type 2 diabetes with nephropathy - A longitudinal randomized clinical trial [J].
Azadbakht, Leila ;
Atabak, Shahnaz ;
Esmaillzadeh, Ahmad .
DIABETES CARE, 2008, 31 (04) :648-654